SEO URLwww.firestrike.ai/deals/lisata-therapeutics-kuva-labs-inc-acquisition-2026
acquisitionAnnounced · Jan 21, 2026pharmaceuticalSource · CredibleArticle · Factual
Kuva Labs, Inc. acquires Lisata Therapeutics
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
—
Target
Lisata Therapeutics
NASDAQ: LSTA · Basking Ridge, New Jersey
Acquirer
Kuva Labs, Inc.
Full Acquisition
Status
Pending
Kuva Labs, Inc. agreed to acquire Lisata Therapeutics. Reported deal value: Undisclosed. Status: Pending. Sector: pharmaceutical. Target headquarters context: Basking Ridge, New Jersey, United States.
This page summarizes publicly available information about the transaction as of 2026-01-21. Figures and status may change as filings and press coverage update.
Lisata Therapeutics , Inc. a clinical-stage pharmaceutical company Wednesday announced that it has entered into a binding term sheet to be acquired by Kuva Labs , Inc. , a preclinical bioscience company developing the proprietary NanoMark direct MR imaging platform
Deal timeline
Announced
Jan 21, 2026 · nasdaq.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in pharmaceutical. Figures and status may change as sources update.
Sources: nasdaq.com · Primary article · FireStrike proprietary index